273 related articles for article (PubMed ID: 19208038)
1. Involvement of PI3K/PTEN/AKT/mTOR pathway in invasion and metastasis in hepatocellular carcinoma: Association with MMP-9.
Chen JS; Wang Q; Fu XH; Huang XH; Chen XL; Cao LQ; Chen LZ; Tan HX; Li W; Bi J; Zhang LJ
Hepatol Res; 2009 Feb; 39(2):177-86. PubMed ID: 19208038
[TBL] [Abstract][Full Text] [Related]
2. Alpha1-ACT Functions as a Tumour Suppressor in Hepatocellular Carcinoma by Inhibiting the PI3K/AKT/mTOR Signalling Pathway via Activation of PTEN.
Zhu H; Liu Q; Tang J; Xie Y; Xu X; Huang R; Zhang Y; Jin K; Sun B
Cell Physiol Biochem; 2017; 41(6):2289-2306. PubMed ID: 28456796
[TBL] [Abstract][Full Text] [Related]
3. Overexpression of Bmi-1 contributes to the invasion and metastasis of hepatocellular carcinoma by increasing the expression of matrix metalloproteinase (MMP)‑2, MMP-9 and vascular endothelial growth factor via the PTEN/PI3K/Akt pathway.
Li X; Yang Z; Song W; Zhou L; Li Q; Tao K; Zhou J; Wang X; Zheng Z; You N; Dou K; Li H
Int J Oncol; 2013 Sep; 43(3):793-802. PubMed ID: 23807724
[TBL] [Abstract][Full Text] [Related]
4. Associations of components of PTEN/AKT/mTOR pathway with cancer stem cell markers and prognostic value of these biomarkers in hepatocellular carcinoma.
Su R; Nan H; Guo H; Ruan Z; Jiang L; Song Y; Nan K
Hepatol Res; 2016 Dec; 46(13):1380-1391. PubMed ID: 26932478
[TBL] [Abstract][Full Text] [Related]
5. PTEN inhibits the migration and invasion of HepG2 cells by coordinately decreasing MMP expression via the PI3K/Akt pathway.
Tian T; Nan KJ; Guo H; Wang WJ; Ruan ZP; Wang SH; Liang X; Lu CX
Oncol Rep; 2010 Jun; 23(6):1593-600. PubMed ID: 20428814
[TBL] [Abstract][Full Text] [Related]
6. A blockade of PD-L1 produced antitumor and antimetastatic effects in an orthotopic mouse pancreatic cancer model via the PI3K/Akt/mTOR signaling pathway.
Zhao L; Li C; Liu F; Zhao Y; Liu J; Hua Y; Liu J; Huang J; Ge C
Onco Targets Ther; 2017; 10():2115-2126. PubMed ID: 28442920
[TBL] [Abstract][Full Text] [Related]
7. Down-regulation of LncRNA NR027113 inhibits cell proliferation and metastasis via PTEN/PI3K/AKT signaling pathway in hepatocellular carcinoma.
Chen Z; Zhou ZY; He CC; Zhang JL; Wang J; Xiao ZY
Eur Rev Med Pharmacol Sci; 2018 Nov; 22(21):7222-7232. PubMed ID: 30468465
[TBL] [Abstract][Full Text] [Related]
8. Suppressive effects of microRNA-16 on the proliferation, invasion and metastasis of hepatocellular carcinoma cells.
Wu WL; Wang WY; Yao WQ; Li GD
Int J Mol Med; 2015 Dec; 36(6):1713-9. PubMed ID: 26499886
[TBL] [Abstract][Full Text] [Related]
9. A detailed immunohistochemical analysis of the PI3K/AKT/mTOR pathway in lung cancer: correlation with PIK3CA, AKT1, K-RAS or PTEN mutational status and clinicopathological features.
Trigka EA; Levidou G; Saetta AA; Chatziandreou I; Tomos P; Thalassinos N; Anastasiou N; Spartalis E; Kavantzas N; Patsouris E; Korkolopoulou P
Oncol Rep; 2013 Aug; 30(2):623-36. PubMed ID: 23728071
[TBL] [Abstract][Full Text] [Related]
10. DAPT suppresses proliferation and migration of hepatocellular carcinoma by regulating the extracellular matrix and inhibiting the Hes1/PTEN/AKT/mTOR signaling pathway.
Qiu K; Ma C; Lu L; Wang J; Chen B; Mao H; Wang Y; Wang H
J Gastrointest Oncol; 2021 Jun; 12(3):1101-1116. PubMed ID: 34295560
[TBL] [Abstract][Full Text] [Related]
11. A comprehensive immunohistochemical and molecular approach to the PI3K/AKT/mTOR (phosphoinositide 3-kinase/v-akt murine thymoma viral oncogene/mammalian target of rapamycin) pathway in bladder urothelial carcinoma.
Korkolopoulou P; Levidou G; Trigka EA; Prekete N; Karlou M; Thymara I; Sakellariou S; Fragkou P; Isaiadis D; Pavlopoulos P; Patsouris E; Saetta AA
BJU Int; 2012 Dec; 110(11 Pt C):E1237-48. PubMed ID: 23107319
[TBL] [Abstract][Full Text] [Related]
12. Activation of PI3K/Akt/mTOR signaling pathway triggered by PTEN downregulation in the pathogenesis of Crohn's disease.
Long SH; He Y; Chen MH; Cao K; Chen YJ; Chen BL; Mao R; Zhang SH; Zhu ZH; Zeng ZR; Hu PJ
J Dig Dis; 2013 Dec; 14(12):662-9. PubMed ID: 23962154
[TBL] [Abstract][Full Text] [Related]
13. Ruscogenin suppressed the hepatocellular carcinoma metastasis via PI3K/Akt/mTOR signaling pathway.
Hua H; Zhu Y; Song YH
Biomed Pharmacother; 2018 May; 101():115-122. PubMed ID: 29477471
[TBL] [Abstract][Full Text] [Related]
14. miR-3691-5p promotes hepatocellular carcinoma cell migration and invasion through activating PI3K/Akt signaling by targeting PTEN.
Du W; Zhang X; Wan Z
Onco Targets Ther; 2019; 12():4897-4906. PubMed ID: 31417285
[No Abstract] [Full Text] [Related]
15. Matrix Stiffness-Upregulated MicroRNA-17-5p Attenuates the Intervention Effects of Metformin on HCC Invasion and Metastasis by Targeting the PTEN/PI3K/Akt Pathway.
Gao X; Qiao X; Xing X; Huang J; Qian J; Wang Y; Zhang Y; Zhang X; Li M; Cui J; Yang Y
Front Oncol; 2020; 10():1563. PubMed ID: 32974191
[TBL] [Abstract][Full Text] [Related]
16. Reciprocal activation between MMP-8 and TGF-β1 stimulates EMT and malignant progression of hepatocellular carcinoma.
Qin G; Luo M; Chen J; Dang Y; Chen G; Li L; Zeng J; Lu Y; Yang J
Cancer Lett; 2016 Apr; 374(1):85-95. PubMed ID: 26872724
[TBL] [Abstract][Full Text] [Related]
17. The expressions of Hedgehog and PI3K-AKT pathway components correlate with invasion and metastasis in hepatocellular carcinoma.
Chen B; Hu Z; Li B; Lin X; Luo Z; Hu Z
Int J Clin Exp Pathol; 2019; 12(6):2381-2388. PubMed ID: 31934065
[TBL] [Abstract][Full Text] [Related]
18. Fibulin-5 inhibits hepatocellular carcinoma cell migration and invasion by down-regulating matrix metalloproteinase-7 expression.
Tu K; Dou C; Zheng X; Li C; Yang W; Yao Y; Liu Q
BMC Cancer; 2014 Dec; 14():938. PubMed ID: 25494879
[TBL] [Abstract][Full Text] [Related]
19. PI3K/Akt/mTOR signaling & its regulator tumour suppressor genes
Makker A; Goel MM; Mahdi AA; Bhatia V; Das V; Agarwal A; Pandey A
Indian J Med Res; 2016 May; 143(Supplement):S112-S119. PubMed ID: 27748285
[TBL] [Abstract][Full Text] [Related]
20. MiR-20a Induces Cell Radioresistance by Activating the PTEN/PI3K/Akt Signaling Pathway in Hepatocellular Carcinoma.
Zhang Y; Zheng L; Ding Y; Li Q; Wang R; Liu T; Sun Q; Yang H; Peng S; Wang W; Chen L
Int J Radiat Oncol Biol Phys; 2015 Aug; 92(5):1132-1140. PubMed ID: 26031366
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]